###### Strengths and limitations of this study

-   Adverse childhood experiences (ACEs) are known to increase individuals' risks of poor health across the life course, yet the financial burden they impose on national economies is largely unmeasured.

-   We combined primary data on ACEs and 13 health outcomes from five general population ACE surveys undertaken in England and Wales.

-   For each outcome, we generated population attributable fractions for cumulative ACE exposure and applied these to disability adjusted life years, which in turn allowed calculation of financial burden of ACEs using a modified human capital approach.

-   ACE data were retrospectively reported and may be affected by recall bias, while general household surveys by their nature are likely to exclude those that have suffered the greatest impact of ACEs (eg, homelessness, incarceration or premature death).

-   Although many major health outcomes were included in the study, data are not yet available on all health outcomes potentially associated with ACEs and financial estimates are likely to be conservative.

Introduction {#s1}
============

Evidence linking adverse childhood experiences (ACEs) to the adoption of health risk behaviours and the development of mental and physical illness has burgeoned in recent years.[@R1] The term ACEs is used to describe some of the most intense sources of stress that children can suffer while growing up, such as being maltreated, witnessing domestic violence or coping with parental substance abuse.[@R2] Such experiences can have harmful effects on children's developing neurological and physiological systems that can embed vulnerability to poor health and well-being. Thus repeated activation of the stress response system during childhood and a lack of responsive interaction with caring adults can impact on brain structure, neuroendocrine stress regulation, immune functioning and metabolic health, as well as social and emotional development.[@R3] Consistent with such effects, ACEs have been associated with delayed child development (eg, cognitive and language skills), childhood health and behavioural conditions, the adoption of health risk behaviours (eg, substance use), mental illness (eg, depression), and early development of chronic health conditions (eg, cancer).[@R1]

Numerous studies have explored the health impacts and costs of specific ACEs such as child maltreatment.[@R9] However, the ACE framework provides a mechanism for measuring a range of ACE types and the cumulative risks they impose at a population level.[@R2] Studies using this approach show a dose--response relationship between the number of ACEs suffered and poor outcomes across multiple domains, including health, criminal justice, education and employment.[@R12] Studies also show that most individuals who report having suffered any specific ACE type (eg, physical abuse) also report other ACE types.[@R16] Consequently, prevention efforts focused on any individual ACE type are likely to have limited success if the range of other ACEs affecting families are left unaddressed. The rapid proliferation of awareness on the impacts of ACEs on the policy priorities of different sectors is driving multiagency action to enhance early intervention and develop trauma-informed services.[@R17] However, such policy development requires an understanding of the financial costs of ACEs to society and consequently the potential gains to be made by preventing ACEs for future generations.

Estimates of the financial burden of ACEs are only just starting to emerge. A recent study estimated that the annual costs attributable to ACEs for four risk factors (smoking, alcohol use, drug use and obesity) and six causes of ill health (anxiety, depression, cancer, diabetes, cardiovascular disease and stroke) reached \$581 billion in Europe and \$748 billion in North America, equivalent to around 3% of each region's gross domestic product (GDP).[@R12] Here, we combine primary data from five ACE studies undertaken in England and Wales to develop national population attributable fractions (PAFs) for ACEs across an extended range of outcomes. We use these data to estimate the annual cost of the health burden resulting from the lifelong impact of ACEs on residents of England and Wales using a modified human capital model.

Methods {#s2}
=======

Primary data sources {#s2-1}
--------------------

We combined data from five cross-sectional ACE studies conducted across various geographies in England and Wales between 2012 and 2017.[@R19] Summary information on each study is provided in [online supplementary table S1](#SP1){ref-type="supplementary-material"}. All studies used stratified random sampling approaches with lower super output area (LSOA; small geographical areas with a mean population of 1500) as the sampling unit. LSOAs were categorised into deprivation quintiles based on their ranking in the English[@R24] or Welsh[@R25] Indexes of Multiple Deprivation, both of which are composite measures including a range of economic and social indicators. Sample selection was stratified by region (as appropriate; see [online supplementary table S1](#SP1){ref-type="supplementary-material"}) then deprivation quintile based on the population profile of the relevant study area. Households in sampled areas were identified using the national postcode address file. In four studies, randomly selected households were sent a letter prior to researcher visits that provided information on the study and the opportunity to opt out. In one study,[@R22] researchers randomly selected households in sampled LSOAs and provided study information materials at the door. Interviews were undertaken face to face at participants' homes by professional market research companies using computer-assisted personal interviewing. Informed consent was obtained from all participants. Sensitive questions, including those on ACEs, were self-completed. Participation was voluntary and anonymous and only one resident participated per selected household (inclusion criteria: within age range, resident in the LSOA, cognitively able to participate in a face-to-face interview). Across the five samples, the weighted average compliance was 55.7% (see [online supplementary table S1](#SP1){ref-type="supplementary-material"}), with a total sample size of 15 658. For this study, data were restricted to individuals aged 18--69 with complete demographic and ACE data, resulting in a final sample of 15 285.
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All questionnaires used the Centers for Disease Control and Prevention short ACE tool[@R26] to collect data on nine ACEs occurring before the age of 18: physical abuse, sexual abuse, verbal abuse, parental separation, exposure to domestic violence, and household member alcohol abuse, drug abuse, mental illness and incarceration. For the purpose of analysis, and in line with previous studies,[@R1] positive responses to ACE questions were summed and participants were allocated to an ACE count category: 0 ACE, 1 ACE, 2--3 ACEs and ≥4 ACEs. Questions used to determine ACEs and the 13 health outcomes analysed in this study are shown in [online supplementary table S2](#SP1){ref-type="supplementary-material"}. All studies provided data on smoking (current smoker), drug use (ever used heroin or crack cocaine) and violence (victimisation in the past year). Four studies provided data on alcohol use (current, ≥12 g per day), high body mass index (BMI, ≥25.0 kg/m^2^), and whether respondents had ever been diagnosed with cancer, type 2 diabetes, heart disease (coronary heart disease/heart attack), stroke or respiratory disease. One study provided data on whether respondents had ever been treated for depression, anxiety and other mental illness (see [online supplementary table S3](#SP1){ref-type="supplementary-material"}). Demographic variables included gender, age, ethnicity (self-assigned using UK census categories) and deprivation quintile.

Calculating PAFs {#s2-2}
----------------

Statistical analysis was undertaken in SPSS V.23, with data editing and calculations undertaken in Excel. Binomial generalised linear modelling was used to calculate risk ratios (RRs) and 95% CIs associated with ACE count level for each health outcome, controlling for study sampling region, deprivation quintile of residence, gender, age and ethnicity (white or non-white). In line with cost estimates for global regions,[@R12] we calculated PAF values at each ACE count level (1 ACE vs 0 ACEs; 2--3 ACEs vs 0 ACE; ≥4 ACEs vs 0 ACE) according to the following:

$$PAF_{ACE\alpha} = \frac{P_{ACE\alpha}x(RR_{ACE\alpha} - 1)}{(P_{ACE0}) + (P_{ACE1}xRR_{ACE1}) + (P_{ACE2 - 3}xRR_{ACE2 - 3}) + (P_{ACE4 +}xRR_{ACE4 +})}$$

where ~α~ is the category of ACE count for the PAF in question, RR~ACE~ is the pooled RR associated with each ACE count, and P~ACE~ is the proportion of the sample exposed to each ACE count. Overall PAFs for ACEs were generated by summing the three PAF values.[@R27] Separate PAFs were generated for England and Wales using regional ACE prevalence levels.

Calculating ACE-attributable costs {#s2-3}
----------------------------------

Consistent with previous studies,[@R11] we used a modified human capital approach to calculate ACE-attributable costs associated with each health outcome. The human capital approach is a commonly used method in economic evaluations to calculate the cost of lost productivity to society as a result of separation of an individual from the labour force due to premature death or morbidity.[@R29] Health outcomes were matched to risk factor and cause categories in the 2017 Global Burden of Disease Study[@R30] (GBD; see [online supplementary table S4](#SP1){ref-type="supplementary-material"}). For each matched category, disability adjusted life years (DALY) estimates were extracted for England and Wales for age categories 15--49 years, 50--69 years and 70+ years. Previous cost estimates using a human capital approach have assumed one DALY is equal to a region's GDP per capita and calculated costs based on DALYs × GDP per capita.[@R11] GDP was not calculated separately for England and Wales; thus, we used the related measure of regional gross value added (GVA; equivalent to GDP plus subsidies less taxes on products), with GVA per capita (balanced, current basic 2017 prices) being £28 096 for England and £19 899 for Wales.[@R31] PAFs were applied to the total cost (by UK region) for each risk factor and cause to estimate the economic value of DALYs by ACE level. The equivalent value of DALYs as a proportion of total GVA was also calculated. To estimate the total costs attributed to ACEs across all health outcomes studied, we excluded DALYs for risk factors that related to included causes of ill health (eg, those for alcohol use attributed to cancer). Sensitivity analyses were run limiting DALYs to individuals aged 15--69 years old, using the upper and lower bounds (uncertainty intervals) for DALYs (extracted from the GBD) and by generating PAFs using the upper and lower CIs for RRs.

Patient and public involvement {#s2-4}
------------------------------

Patients and the public were not involved in the design or planning of the study.

Results {#s3}
=======

Demographics and ACE count levels of the individual and combined study samples are shown in [online supplementary table S5](#SP1){ref-type="supplementary-material"}. Across the combined samples, over half (54.9%) of participants were female and 85.7% were of white ethnicity. ACE prevalence levels (used to generate PAFs) were 53.1% for 0 ACE, 19.0% for 1 ACE, 15.2% for 2--3 ACEs and 12.6% for ≥4 ACEs in Welsh samples, and 56.2% for 0 ACE, 20.1% for 1 ACE, 15.4% for 2--3 ACEs and 8.4% for ≥4 ACEs in English samples.

RRs for each ACE count level and each health outcome are presented in [table 1](#T1){ref-type="table"} (unadjusted proportions are provided in [online supplementary table S6](#SP1){ref-type="supplementary-material"}). All outcomes showed a graded relationship with ACEs, with RRs increasing as ACE count increased. Risks of alcohol use, smoking, drug use, violence and mental illness outcomes were increased in individuals with any level of ACEs. Risks of high BMI, heart disease and respiratory disease were increased in individuals with ≥2 ACEs, and risks of type 2 diabetes, cancer and stroke in those with ≥4 ACEs only.

###### 

Risk ratios for risk factors and causes of ill health at each ACE count level

                          1 ACE   2--3 ACEs        ≥4 ACEs                                                                
  ----------------------- ------- ---------------- --------- ------- ---------------- --------- ------- ----------------- ---------
  Risk factors                                                                                                            
   Alcohol use            1.164   1.041 to 1.301   0.008     1.311   1.165 to 1.475   \<0.001   1.837   1.631 to 2.069    \<0.001
   Smoking                1.188   1.091 to 1.293   \<0.001   1.448   1.329 to 1.578   \<0.001   2.079   1.904 to 2.270    \<0.001
   Drug use               1.648   1.168 to 2.327   0.005     3.184   2.342 to 4.330   \<0.001   8.685   6.658 to 11.328   \<0.001
   High BMI               1.031   0.986 to 1.078   0.177     1.062   1.012 to 1.115   0.015     1.075   1.011 to 1.142    0.020
  Causes of ill health                                                                                                    
   Depression             1.560   1.305 to 1.865   \<0.001   2.137   1.820 to 2.509   \<0.001   2.766   2.374 to 3.223    \<0.001
   Anxiety                1.429   1.169 to 1.747   \<0.001   2.151   1.806 to 2.563   \<0.001   2.751   2.316 to 3.266    \<0.001
   Other mental illness   1.684   1.008 to 2.812   0.046     3.216   2.083 to 4.964   \<0.001   5.115   3.356 to 7.796    \<0.001
   Violence               1.383   1.107 to 1.728   0.004     2.955   2.448 to 3.566   \<0.001   5.625   4.745 to 6.667    \<0.001
   Cancer                 1.009   0.800 to 1.273   0.937     1.101   0.854 to 1.419   0.459     2.078   1.588 to 2.720    \<0.001
   Type 2 diabetes        1.157   0.958 to 1.398   0.131     1.223   0.995 to 1.503   0.056     1.782   1.400 to 2.268    \<0.001
   Heart disease          1.102   0.836 to 1.453   0.492     1.415   1.072 to 1.868   0.014     1.928   1.366 to 2.722    \<0.001
   Stroke                 1.238   0.800 to 1.918   0.338     1.427   0.906 to 2.250   0.125     2.705   1.660 to 4.409    \<0.001
   Respiratory disease    1.224   0.927 to 1.615   0.155     1.806   1.383 to 2.358   \<0.001   2.612   1.929 to 3.536    \<0.001

Analysis used generalised linear modelling controlling for study sampling region, deprivation quintile, age, gender and ethnicity.

Reference category: 0 ACE.

ACE, adverse childhood experience; BMI, body mass index; CI, confidence interval; RR, risk ratio.

The total PAFs for ACEs were slightly higher in Wales than in England for all outcomes due to higher ACE prevalence levels ([table 2](#T2){ref-type="table"}). Across the four risk factors, drug use had the highest PAFs due to ACEs (58.8% Wales, 52.6% England). However, smoking carried the highest ACE-attributable costs given the higher number of DALYs for this risk factor. ACE-attributable costs due to smoking were £7.4 billion in England and £466.5 million in Wales. High BMI had the lowest PAFs due to ACEs (2.4% Wales, 2.2% England), although ACE-attributable costs still reached £729.2 million in England and £35.3 million in Wales. Across causes of ill health, violence and mental illness had the highest PAFs due to ACEs, while cancer and type 2 diabetes had the lowest. ACEs were attributed to 48.9% of recent violence victimisation in Wales and 43.4% in England, with associated costs of £16.6 million and £355.0 million, respectively. Up to a third of depression and anxiety and almost half of other mental illnesses were attributed to ACEs, with associated costs across the three mental health outcomes being £465.3 million in Wales and £10.7 billion in England. Despite having low PAFs, high DALYs for cancer meant that this cause carried the greatest ACE-attributable costs across all individual outcomes measured, reaching £476.4 million in Wales and £7.5 billion in England.

###### 

Population attributable fractions and DALYs and costs attributable to ACEs

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                         Population attributable fraction   Total DALYs (age 15+)   DALYs attributable to ACEs   Total estimated cost\   Attributable costs by ACE count\                                                                               
                                                                                                                 (£ million)\*           (£ million)                                                                                                    
  ---------------------- ---------------------------------- ----------------------- ---------------------------- ----------------------- ---------------------------------- -------- -------- --------- --------- ---------- -------- -------- -------- --------
  Alcohol use                                                                                                                                                                                                                                           

   Wales                 0.026                              0.040                   0.089                        0.156                   38 114                             999      1527     3404      5929      758.4      19.9     30.4     67.7     118.0

   England               0.029                              0.042                   0.061                        0.131                   606 086                            17 297   25 199   36 972    79 467    17 028.6   486.0    708.0    1038.8   2232.7

  Smoking                                                                                                                                                                                                                                               

   Wales                 0.029                              0.055                   0.110                        0.194                   121 011                            3474     6663     13 307    23 444    2408.0     69.1     132.6    264.8    466.5

   England               0.031                              0.058                   0.076                        0.165                   1 590 656                          50 082   91 530   120 314   261 926   44 691.1   1407.1   2571.6   3380.3   7359.1

  Drug use                                                                                                                                                                                                                                              

   Wales                 0.051                              0.137                   0.400                        0.588                   22 518                             1140     3090     9011      13 241    448.1      22.7     61.5     179.3    263.5

   England               0.062                              0.159                   0.306                        0.526                   331 956                            20 459   52 832   101 413   174 704   9326.6     574.8    1484.4   2849.3   4908.5

  High BMI                                                                                                                                                                                                                                              

   Wales                 0.006                              0.009                   0.009                        0.024                   73 423                             422      677      677       1775      1461.0     8.4      13.5     13.5     35.3

   England               0.006                              0.009                   0.006                        0.022                   1 203 925                          7346     11 219   7388      25 954    33 825.5   206.4    315.2    207.6    729.2

  Depression                                                                                                                                                                                                                                            

   Wales                 0.071                              0.115                   0.149                        0.335                   16 161                             1142     1865     2401      5407      321.6      22.7     37.1     47.8     107.6

   England               0.078                              0.122                   0.103                        0.303                   294 592                            23 073   35 890   30 416    89 379    8276.9     648.3    1008.4   854.6    2511.2

  Anxiety                                                                                                                                                                                                                                               

   Wales                 0.055                              0.119                   0.150                        0.324                   12 434                             684      1477     1861      4023      247.4      13.6     29.4     37.0     80.0

   England               0.061                              0.126                   0.104                        0.291                   203 872                            12 452   25 606   21 239    59 297    5728.0     349.9    719.4    596.7    1666.0

  Other mental illness                                                                                                                                                                                                                                  

   Wales                 0.065                              0.170                   0.262                        0.497                   28 076                             1832     4772     7347      13 951    558.7      36.5     95.0     146.2    277.6

   England               0.075                              0.187                   0.189                        0.452                   517 544                            38 976   96 724   98 011    233 711   14 540.9   1095.1   2717.6   2753.7   6566.3

  Violence                                                                                                                                                                                                                                              

   Wales                 0.037                              0.152                   0.299                        0.489                   1703                               63       260      509       832       33.9       1.3      5.2      10.1     16.6

   England               0.044                              0.170                   0.220                        0.434                   29 134                             1270     4961     6404      12 635    818.6      35.7     139.4    179.9    355.0

  Cancer                                                                                                                                                                                                                                                

   Wales                 0.002                              0.013                   0.118                        0.133                   179 919                            279      2397     21 263    23 939    3580.2     5.6      47.7     423.1    476.4

   England               0.002                              0.014                   0.082                        0.097                   2 725 146                          4666     38 124   222 605   265 395   76 565.7   131.1    1071.1   6254.3   7456.5

  Type 2 diabetes                                                                                                                                                                                                                                       

   Wales                 0.026                              0.029                   0.085                        0.140                   23 306                             597      681      1982      3260      463.8      11.9     13.5     39.4     64.9

   England               0.028                              0.030                   0.058                        0.116                   356 871                            9939     10 802   20 707    41 448    10 026.6   279.2    303.5    581.8    1164.5

  Heart disease                                                                                                                                                                                                                                         

   Wales                 0.016                              0.053                   0.098                        0.167                   77 275                             1243     4077     7556      12 877    1537.7     24.7     81.1     150.4    256.2

   England               0.018                              0.055                   0.067                        0.140                   1 049 623                          18 461   57 674   70 352    146 487   29 490.2   518.7    1620.4   1976.6   4115.7

  Stroke                                                                                                                                                                                                                                                

   Wales                 0.034                              0.049                   0.163                        0.246                   39 189                             1336     1926     6372      9634      779.8      26.6     38.3     126.8    191.7

   England               0.038                              0.052                   0.114                        0.204                   546 308                            20 801   28 579   62 218    111 597   15 349.1   584.4    802.9    1748.1   3135.4

  Respiratory disease                                                                                                                                                                                                                                   

   Wales                 0.031                              0.090                   0.149                        0.270                   50 697                             1570     4550     7545      13 664    1008.8     31.2     90.5     150.1    271.9

   England               0.034                              0.095                   0.104                        0.233                   784 621                            27 000   74 559   81 386    182 945   22 044.7   758.6    2094.8   2286.6   5140.0
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Calculated as 1 DALY=GVA per capita (£19 899 Wales, £28 096 England; balanced, current basic prices, 2017).

ACE, adverse childhood experience; BMI, body mass index; DALY, disability adjusted life year; GVA, gross value added.

Across all nine causes of ill health, the total ACE-attributable cost was £33.9 billion (£1.7 billion for Wales and £32.1 billion for England). To calculate the total ACE-attributable cost across all risk factors and causes of ill health, we excluded DALYs from the four risk factors that related to included causes (eg, those for smoking related to cancer). The total ACE-attributable cost was £42.8 billion (£2.2 billion for Wales and £40.6 billion for England; [table 3](#T3){ref-type="table"}). These costs are equivalent to 3.5% of the total annual GVA in Wales and 2.6% in England (2.6% across the combined geographies). In sensitivity analysis (see the Methods section), combined estimated ACE-attributable costs for England and Wales ranged from £16.3 billion (equivalent to 1.0% of GVA) to £68.4 billion (4.2% of GVA; [table 3](#T3){ref-type="table"}).

###### 

Total ACE-attributable DALYs and costs and sensitivity analyses

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                           ACE-attributable DALYs (thousands)   ACE-attributable costs\   Equivalent % of GVA                                   
                                                                                                (£ billion)                                                                     
  -------------------------------------------------------- ------------------------------------ ------------------------- --------------------- ------ ----- ------ ----- ----- -----
  Best estimate                                            1444.9                               110.0                     1554.9                40.6   2.2   42.8   2.6   3.5   2.6

  Limited to DALYs for individuals aged 15--69 years old   956.4                                69.5                      1025.8                26.9   1.4   28.3   1.7   2.2   1.7

  PAFs generated using lower CIs for RRs                   546.7                                47.7                      594.4                 15.4   0.9   16.3   1.0   1.5   1.0

  PAFs generated using upper CIs for RRs                   2314.3                               169.0                     2483.2                65.0   3.4   68.4   4.2   5.4   4.2

  Lower bound (uncertainty interval) for DALYs             1273.7                               96.0                      1369.8                35.8   1.9   37.7   2.3   3.1   2.3

  Upper bound (uncertainty interval) for DALYs             1638.6                               126.0                     1764.7                46.0   2.5   48.5   2.9   4.0   3.0
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ACE, adverse childhood experience; DALY, disability adjusted life year; GVA, gross value added; PAF, population attributable fraction; RR, risk ratio.

[Figure 1](#F1){ref-type="fig"} shows the proportion of ACE-attributable costs for each outcome that were accounted for by 1, 2--3 and ≥4 ACEs. For cancer, the 1 ACE category accounted for only 1.7% of ACE-attributable financial costs, while the ≥4 ACEs category accounted for 84.2%. For other outcomes, the proportion of costs accounted for by the 1 ACE category ranged from 9.9% (violence) to 28.1% (high BMI), while the proportion accounted for by ≥4 ACEs ranged from 28.9% (high BMI) to 58.6% (drug use).

![Proportion of ACE-attributable costs for each risk factor and cause of ill health attributed to 1, 2--3 and ≥4 ACE categories. ACE, adverse childhood experience; BMI, body mass index.](bmjopen-2019-036374f01){#F1}

Discussion {#s4}
==========

In this study of 15 285 adults in England and Wales, we found a dose--response relationship between ACEs and all outcomes measured. Violence, mental illness and drug use had the highest PAFs due to ACEs, while mental illness, cancer and smoking carried the highest ACE-attributable costs. Across all outcomes studied, the total estimated annual ACE-attributable cost across England and Wales was £42.8 billion, equivalent to 2.6% of the total GVA in England and Wales and representing approximately £1800 per household per annum.[@R32] The majority of these costs related to multiple ACE categories.

Comparison with other studies {#s4-1}
-----------------------------

There are no previous studies estimating the costs of ACEs in England and Wales. However, a study that generated PAFs for ACEs through meta-analyses of risk estimates in published literature estimated the annual costs of ACEs to be equivalent to 2.7% of GDP in Europe and 3.6% of GDP in North America.[@R12] Other studies have measured the costs of specific ACEs, particularly violence against children, using similar human capital approaches. Such costs have been estimated to be equivalent to between 1.2% and 3.5% of subregional GDP in East Asia and the Pacific[@R11]; to 4.3% of GDP in South Africa[@R33]; and to 0.8% of GDP for physical abuse, 0.5% for emotional abuse and 0.4% for sexual abuse in China.[@R34] In the UK, the lifetime cost per victim of non-fatal child maltreatment by a primary caregiver has conservatively been estimated at £90 000.[@R35] However, this estimate excluded costs for several outcomes considered in our study, including those for cancer, type 2 diabetes and heart disease, due to no association being found between these conditions and the study's single measure of child maltreatment. We found no associations between such conditions and the single ACE category, yet strong associations with multiple ACEs. Thus 98.3% of the ACE-attributable costs of cancer, 87.6% of those for heart disease and 76.3% of those for type 2 diabetes were accounted for by suffering more than one type of ACE.

Strengths and weaknesses of the study {#s4-2}
-------------------------------------

We used an established methodology[@R11] and based our approach on that used to estimate the financial burden of ACEs across Europe and North America.[@R12] An acknowledged limitation of this previous study was the lack of consistency in study methodologies. Key strengths of the current study are the use of primary data and consistency in study methodologies, with all studies using representative household samples and the same set of questions to measure ACEs. However not all outcomes were measured in all studies, and mental illness was only measured in Wales,[@R23] while some outcome measures could not be matched directly to GBD categories (see [online supplementary table S4](#SP1){ref-type="supplementary-material"}). Like previous ACE studies, the retrospective, self-reported nature of questions makes findings subject to recall issues and any reluctance to report historical experiences. Further, some population groups who may be at increased exposure to ACEs (eg, those incarcerated[@R36] or homeless[@R37]) will have been under-represented and we could not account for individuals that had died prematurely through conditions related to ACEs. These biases may have led to reduced relative risks. Conversely, while ACEs made an overall significant contribution to GLMs (generalised linear models) for all outcomes, for some, RRs were not significant at all ACE levels. Further, our samples were restricted to adults aged 18--69 years, yet some conditions such as stroke occur predominantly in older age groups. Consequently sensitivity analyses were undertaken limiting DALYs to the 15--69 years age group and using lower and upper CIs for RRs. While we excluded DALYs for risk factors linked to included causes of ill health in calculating our overall cost estimates, it is beyond the ability of this study to calculate the actual burden of ACEs due to multiplicative relationships. However, our estimates of the costs of ACEs are likely to be conservative. While we included many key risks for, and causes of, ill health associated with ACEs, we did not account for other associated outcomes (eg, risky sexual behaviour, suicide, crime), nor for the burden of child deaths related to ACEs. A study of child death reviews in an English locality found evidence of at least one ACE in the records of 63% of children that died over a 4-year period and of at least four ACEs in 20% of cases.[@R38] The lifetime cost of a child maltreatment death in the UK has been estimated at almost £1 million.[@R35]

Meaning of the study {#s4-3}
--------------------

Nearly half of all adults in England and Wales experienced some form of ACE as a child and around one in ten experienced ≥4 ACEs (see [online supplementary table S5](#SP1){ref-type="supplementary-material"}). This equates to approximately 20 million adults with any ACE and four million with ≥4 ACEs. Our results quantify the substantive proportion of common health-harming behaviours and long-term health conditions that are associated with ACEs, and consequently that could be avoided in future generations through offering better quality childhoods. Currently, however, an estimated 2.3 million children in England live in families with substantial complex needs and only a third of these children are receiving established support from statutory services.[@R39] An imperative to increase expenditure on safe and nurturing childhoods is emphasised by findings that around a third of mental illness could be avoided if ACEs were either prevented or their impacts moderated through early intervention. Mental illness carries one of the highest costs to health systems in England and Wales[@R40] and also creates substantial pressure on educational, social and criminal justice systems. For the latter in particular, strong relationships found here between ACEs and violence are an additional concern with many types of police-recorded violence increasing in England and Wales.[@R41] Across all measured outcomes, we identify potentially avoidable costs from ACEs equivalent to more than a quarter of the UK's annual government healthcare expenditure.[@R42] The potential to avoid such costs is unrealised while the majority of health expenditure focuses on adults who have already developed pathologies. Evidence-based mechanisms to prevent ACEs and build resilience to their long-term harms are available, offering return on investments in years rather than decades through benefits on child development, health and education.[@R43] The benefits of such interventions reach across sectors, and a whole of government approach could more immediately resource interventions capable of diminishing a current annual ACE burden of almost £43 billion.

Unanswered questions and future research {#s4-4}
----------------------------------------

As with most ACE studies our data were collected retrospectively and consequently provide no information on the current levels of ACEs experienced by children in England and Wales. Options to measure ACE prevalence now form part of the international Health Behaviour in School-aged Children Survey[@R47] but have not yet been used in the English or Welsh survey iterations, nor are such data routinely being collected through other major school-based surveys in the UK. While estimates of current exposure to some ACEs are available,[@R39] routine measurement of ACEs in children is required to better understand their extent and sociodemographic and geographical distribution, as well as the impact of interventions to address them. Further, our findings identified that, despite having the lowest prevalence, the majority of costs generated by ACEs fall on those experiencing ≥4 ACEs ([table 2](#T2){ref-type="table"}). There is an urgent need to better understand the cumulative impact of ACEs on health outcomes across the life course, integrating epidemiology with fields including epigenetics, immunology and neurology. Equally, there is a critical need for knowledge on how services can become more trauma-informed, what impact trauma-informed service delivery can have, and how services for children and families affected by child maltreatment, substance abuse, domestic violence or incarceration, for instance, can be better integrated to provide a cohesive offer. Finally, as well as the core ACE categories included here, measurements of other childhood adversities such as neglect, parental bereavement, bullying and exposure to community level violence are increasingly being incorporated into the list of potential ACEs. Public services that recognise the impact of childhood adversity on lifelong health but neglect to implement preventative measures may yet feature in future lists.
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